A review of three-dimensional in vitro tissue models for drug discovery and transport studies

Journal of Pharmaceutical Sciences

Volumn 100, Issue 1, 2011, Pages 59-74

  Elliott, Nelita T ^a   Yuan, Fan ^a  

^a Duke University   (United States)

Author keywords

Cancer; Cell culture; in vitro models; Tissue engineering; Transport

Indexed keywords

BONE TISSUE; BREAST; CANCER TISSUE; CELL CULTURE; CELL INTERACTION; CORNEA; EXTRACELLULAR MATRIX; HEART; IN VITRO STUDY; LIVER; MICROFLUIDICS; MODEL; MULTICELLULAR SPHEROID; REVIEW; SKELETAL MUSCLE; THREE DIMENSIONAL TISSUE MODEL; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE;

EID: 78650062139     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22257     Document Type: Review

References (200)

1. Newsam JM, King-Smith D, Jain A, Karande P, Feygin I, Burbaum J, Gowrishankar TR, Sergeeva M, Mitragotri S. 2005. Screening soft materials for their effect on skin barrier function by high throughput experimentation. J Mater Chem 15: 3061-3068.
2. Griffith LG, Swartz MA. 2006. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7: 211-224.
3. Yamada KM, Cukierman E. 2007. Modeling tissue morphogenesis and cancer in 3D. Cell 130: 601-610.
4. Nelson CM, Bissell MJ. 2005. Modeling dynamic reciprocity: Engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 15: 342-352.
5. Folkman J, Greenspan HP. 1975. Influence of geometry on control of cell growth. Biochim Biophys Acta 417: 211-236.
6. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A, Van Dyke ME, Kaplan D, Vunjak-Novakovic G. 2006. Engineering complex tissues. Tissue Eng 12: 3307-3339.
7. Sniadecki NJ, Desai RA, Ruiz SA, Chen CS. 2006. Nanotechnology for cell-substrate interactions. Ann Biomed Eng 34: 59-74.
8. Kane RS, Takayama S, Ostuni E, Ingber DE, Whitesides GM. 1999. Patterning proteins and cells using soft lithography. Biomaterials 20: 2363-2376.
9. Fischer RS, Gardel M, Ma X, Adelstein RS, Waterman CM. 2009. Local cortical tension by myosin II guides 3D endothelial cell branching. Curr Biol 19: 260-265.
10. Liu WF, Chen CS. 2007. Cellular and multicellular form and function. Adv Drug Deliv Rev 59: 1319-1328.
11. Soucy PA, Romer LH. 2009. Endothelial cell adhesion, signaling, and morphogenesis in fibroblast-derived matrix. Matrix Biol 28: 273-283.
12. Discher DE, Mooney DJ, Zandstra PW. 2009. Growth factors, matrices, and forces combine and control stem cells. Science 324: 1673-1677.
13. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang HY, Speicher DW, Sanger JW, Sanger JM, Discher DE. 2008. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: Scar-like rigidity inhibits beating. J Cell Sci 121: 3794-3802.
14. Mitragotri S, Lahann J. 2009. Physical approaches to biomaterial design. Nature Mater 8: 15-23.
15. Keenan TM, Folch A. 2008. Biomolecular gradients in cell culture systems. Lab Chip 8: 34-57.
16. Kim SM, Lee SH, Suh KY. 2008. Cell research with physically modified microfluidic channels: A review. Lab Chip 8: 1015-1023.
17. Meyvantsson I, Warrick JW, Hayes S, Skoien A, Beebe DJ. 2008. Automated cell culture in high density tubeless microfluidic device arrays. Lab Chip 8: 717-724.
18. Park H, Cannizzaro C, Vunjak-Novakovic G, Langer R, Vacanti CA, Farokhzad OC. 2007. Nanofabrication and microfabrication of functional materials for tissue engineering. Tissue Eng 13: 1867-1877.
19. Sun W, Lal P. 2002. Recent development on computer aided tissue engineering-A review. Comput Methods Programs Biomed 67: 85-103.
20. Tsang VL, Bhatia SN. 2004. Three-dimensional tissue fabrication. Adv Drug Deliv Rev 56: 1635-1647.
21. Byers BA, Guldberg RE, Garcia AJ. 2004. Synergy between genetic and tissue engineering: Runx2 overexpression and in vitro construct development enhance in vivo mineralization. Tissue Eng 10: 1757-1766.
22. Byers BA, Guldberg RE, Hutmacher DW, Garcia AJ. 2006. Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects. J Biomed Mater Res A 76: 646-655.
23. Cartmell S, Huynh K, Lin A, Nagaraja S, Guldberg R. 2004. Quantitative microcomputed tomography analysis of mineralization within three-dimensional scaffolds in vitro. J Biomed Mater Res A 69: 97-104.
24. Cartmell SH, Porter BD, Garcia AJ, Guldberg RE. 2003. Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Eng 9: 1197-1203.
25. Gersbach CA, Byers BA, Pavlath GK, Guldberg RE, Garcia AJ. 2004. Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro. Biotechnol Bioeng 88: 369-378.
26. Holy CE, Shoichet MS, Davies JE. 2000. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: Investigating initial cell-seeding density and culture period. J Biomed Mater Res 51: 376-382.
27. Hosseinkhani H, Azzam T, Kobayashi H, Hiraoka Y, Shimokawa H, Domb AJ, Tabata Y. 2006. Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells. Biomaterials. 27: 4269-4278.
28. Niemeyer P, Krause U, Punzel M, Fellenberg J, Simank HG. 2003. Mesenchymal stem cells for tissue engineering of bone: 3D-cultivation and osteogenic differentiation on mineralized collagen. Z Orthop Ihre Grenzgeb 141: 712-717.
29. Rouwkema J, de Boer J, Van Blitterswijk CA. 2006. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 12: 2685-2693.
30. Schieker M, Seitz S, Gulkan H, Nentwich M, Horvath G, Regauer M, Milz S, Mutschler W. 2004. Tissue engineering of bone. Integration and migration of human mesenchymal stem cells in colonized contructs in a murine model. Orthopade 33: 1354-1360.
31. Sun JS, Tsuang YH, Lin FH, Liu HC, Tsai CZ, Chang WH. 1999. Bone defect healing enhanced by ultrasound stimulation: An in vitro tissue culture model. J Biomed Mater Res 46: 253-261.
32. Tan KK, Aminuddin BS, Tan GH, Sabarul Afian M, Ng MH, Fauziah O, Ruszymah BH. 2004. Strategy for generating tissue-engineered human bone construct. Med J Malaysia 59: 43-44.
33. Torricelli P, Fini M, Giavaresi G, Giardino R. 2001. Bone tissue cultures: An in vitro model for the evaluation of bone defect healing after L-arginine and L-lysine administration. Artif Cells Blood Substit Immobil Biotechnol 29: 325-334.
34. Wang R, Xu J, Juliette L, Castilleja A, Love J, Sung SY, Zhau HE, Goodwin TJ, Chung LW. 2005. Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone. Semin Cancer Biol 15: 353-364.
35. Botchwey EA, Dupree MA, Pollack SR, Levine EM, Laurencin CT. 2003. Tissue engineered bone: Measurement of nutrient transport in three-dimensional matrices. J Biomed Mater Res A 67: 357-367.
36. Braccini A, Wendt D, Jaquiery C, Jakob M, Heberer M, Kenins L, Wodnar-Filipowicz A, Quarto R, Martin I. 2005. Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23: 1066-1072.
37. Auth MK, Okamoto M, Ishida Y, Keogh A, Auth SH, Gerlach J, Encke A, McMaster P, Strain AJ. 1998. Maintained function of primary human hepatocytes by cellular interactions in coculture: Implications for liver support systems. Transpl Int 11: S439-S443.
38. Bader A, Knop E, Fruhauf N, Crome O, Boker K, Christians U, Oldhafer K, Ringe B, Pichlmayr R, Sewing KF. 1995. Reconstruction of liver tissue in vitro: Geometry of characteristic flat bed, hollow fiber, and spouted bed bioreactors with reference to the in vivo liver. Artif Organs 19: 941-950.
39. Bader A, Knop E, Kern A, Boker K, Fruhauf N, Crome O, Esselmann H, Pape C, Kempka G, Sewing KF. 1996. 3-D coculture of hepatic sinusoidal cells with primary hepatocytes-design of an organotypical model. Exp Cell Res 226: 223-233.
40. Baharvand H, Hashemi SM, Kazemi Ashtiani S, Farrokhi A. 2006. Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 50: 645-652.
41. Guthke R, Zeilinger K, Sickinger S, Schmidt-Heck W, Buentemeyer H, Iding K, Lehmann J, Pfaff M, Pless G, Gerlach JC. 2006. Dynamics of amino acid metabolism of primary human liver cells in 3D bioreactors. Bioprocess Biosyst Eng 28: 331-340.
42. Landry J, Bernier D, Ouellet C, Goyette R, Marceau N. 1985. Spheroidal aggregate culture of rat liver cells: Histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol 101: 914-923.
43. Riccalton-Banks L, Liew C, Bhandari R, Fry J, Shakesheff K. 2003. Long-term culture of functional liver tissue: Three-dimensional coculture of primary hepatocytes and stellate cells. Tissue Eng 9: 401-410.
44. Sargiacomo M, Onori P, Bravo E, Franchitto A, Cantafora A, Barca S, Peschle C, Gaudio E. 1998. Long-term cultures of human fetal liver cells: A three-dimensional experimental model for monitoring liver tissue development. J Hepatol 28: 480-490.
45. Sivaraman A, Leach JK, Townsend S, Iida T, Hogan BJ, Stolz DB, Fry R, Samson LD, Tannenbaum SR, Griffith LG. 2005. A microscale in vitro physiological model of the liver: Predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 6: 569-591.
46. Thomas RJ, Bhandari R, Barrett DA, Bennett AJ, Fry JR, Powe D, Thomson BJ, Shakesheff KM. 2005. The effect of three-dimensional co-culture of hepatocytes and hepatic stellate cells on key hepatocyte functions in vitro. Cells Tissues Organs 181: 67-79.
47. Verrill C, Davies J, Millward-Sadler H, Sundstrom L, Sheron N. 2002. Organotypic liver culture in a fluid-air interface using slices of neonatal rat and adult human tissue-A model of fibrosis in vitro. J Pharmacol Toxicol Methods 48: 103-110.
48. Zeilinger K, Sauer IM, Pless G, Strobel C, Rudzitis J, Wang A, Nussler AK, Grebe A, Mao L, Auth SH, Unger J, Neuhaus P, Gerlach JC. 2002. Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: Effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions. Altern Lab Anim 30: 525-538.
49. Pomahac B, Svensjo T, Yao F, Brown H, Eriksson E. 1998. Tissue engineering of skin. Crit Rev Oral Biol Med 9: 333-344.
50. Bartholoma P, Gorjup E, Monz D, Reininger-Mack A, Thielecke H, Robitzki A. 2005. Three-dimensional in vitro reaggregates of embryonic cardiomyocytes: A potential model system for monitoring effects of bioactive agents. J Biomol Screen 10: 814-822.
51. Bursac N, Papadaki M, Cohen RJ, Schoen FJ, Eisenberg SR, Carrier R, Vunjak-Novakovic G, Freed LE. 1999. Cardiac muscle tissue engineering: Toward an in vitro model for electrophysiological studies. Am J Physiol 277: H433-H444.
52. Bursac N, Parker KK, Iravanian S, Tung L. 2002. Cardiomyocyte cultures with controlled macroscopic anisotropy: A model for functional electrophysiological studies of cardiac muscle. Circ Res 91: e45-e54.
53. Eschenhagen T, Didie M, Munzel F, Schubert P, Schneiderbanger K, Zimmermann WH. 2002. 3D engineered heart tissue for replacement therapy. Basic Res Cardiol 97: I146-152.
54. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schafer H, Bishopric N, Wakatsuki T, Elson EL. 1997. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: A new heart muscle model system. FASEB J 11: 683-694.
55. Evans HJ, Sweet JK, Price RL, Yost M, Goodwin RL. 2003. Novel 3D culture system for study of cardiac myocyte development. Am J Physiol Heart Circ Physiol 285: H570-H578.
56. Just L, Kursten A, Borth-Bruhns T, Lindenmaier W, Rohde M, Dittmar K, Bader A. 2006. Formation of three-dimensional fetal myocardial tissue cultures from rat for long-term cultivation. Dev Dyn 235: 2200-2209.
57. Kofidis T, Akhyari P, Boublik J, Theodorou P, Martin U, Ruhparwar A, Fischer S, Eschenhagen T, Kubis HP, Kraft T, Leyh R, Haverich A. 2002. In vitro engineering of heart muscle: Artificial myocardial tissue. J Thorac Cardiovasc Surg 124: 63-69.
58. Zimmermann WH, Schneiderbanger K, Schubert P, Didie M, Munzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T. 2002. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90: 223-230.
59. Giorgio TD, Moscioni AD, Rozga J, Demetriou AA. 1993. Mass transfer in a hollow fiber device used as a bioartificial liver. ASAIO J 39: 886-892.
60. Rozga J, Holzman MD, Ro MS, Griffin DW, Neuzil DF, Giorgio T, Moscioni AD, Demetriou AA. 1993. Development of a hybrid bioartificial liver. Ann Surg 217: 502-509, discussion 509-511.
61. Rozga J, Williams F, Ro MS, Neuzil DF, Giorgio TD, Backfisch G, Moscioni AD, Hakim R, Demetriou AA. 1993. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 17: 258-265.
62. Nonaka H, Ise H, Sugihara N, Hirose S, Negishi N, Kondo Y, Akaike T. 2003. Development of highly functional long-term culture method of liver slice embedded in agarose gel for bioartificial liver. Cell Transplant 12: 491-498.
63. Wang X, Yan Y, Lin F, Xiong Z, Wu R, Zhang R, Lu Q. 2005. Preparation and characterization of a collagen/chitosan/heparin matrix for an implantable bioartificial liver. J Biomater Sci Polym Ed 16: 1063-1080.
64. Wang YJ, Li MD, Wang YM, Nie QH, Chen GZ. 1999. Experimental study of bioartificial liver with cultured human liver cells. World J Gastroenterol 5: 135-137.
65. Wu FJ, Friend JR, Lazar A, Mann HJ, Remmel RP, Cerra FB, Hu WS. 1996. Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. Biotechnol Bioeng 52: 34-44.
66. Xu Q, Sun X, Qiu Y, Zhang H, Ding Y. 2004. The optimal hepatocyte density for a hollow-fiber bioartificial liver. Ann Clin Lab Sci 34: 87-93.
67. Xu Q, Yu D, Qiu Y, Zhang H, Ding Y. 2003. Function of a new internal bioartificial liver: An in vitro study. Ann Clin Lab Sci 33: 306-312.
68. Griffith LG, Wu B, Cima MJ, Powers MJ, Chaignaud B, Vacanti JP. 1997. In vitro organogenesis of liver tissue. Ann NY Acad Sci 831: 382-397.
69. Lee J, Lilly GD, Doty RC, Podsiadlo P, Kotov NA. 2009. In vitro toxicity testing of nanoparticles in 3D cell culture. Small 5: 1213-1221.
70. Kienhuis AS, Wortelboer HM, Hoflack JC, Moonen EJ, Kleinjans JC, van Ommen B, van Delft JH, Stierum RH. 2006. Comparison of coumarin-induced toxicity between sandwich-cultured primary rat hepatocytes and rats in vivo: A toxicogenomics approach. Drug Metab Dispos 34: 2083-2090.
71. Kern A, Bader A, Pichlmayr R, Sewing KF. 1997. Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochem Pharmacol 54: 761-772.
72. Born SL, Caudill D, Fliter KL, Purdon MP. 2002. Identification of the cytochromes P450 that catalyze coumarin 3, 4-epoxidation and 3-hydroxylation. Drug Metab Dispos 30: 483-487.
73. Miranda JP, Leite SB, Muller-Vieira U, Rodrigues A, Carrondo MJ, Alves PM. 2008. Toward extended functional hepatocyte in vitro culture. Tissue Eng Part C Methods.
74. Mabuchi A, Mullaney I, Sheard PW, Hessian PA, Mallard BL, Tawadrous MN, Zimmermann A, Senoo H, Wheatley AM. 2004. Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the rat. J Hepatol 40: 910-916.
75. Thomas RJ, Bennett A, Thomson B, Shakesheff KM. 2006. Hepatic stellate cells on poly(DL-lactic acid) surfaces control the formation of 3D hepatocyte co-culture aggregates in vitro. Eur Cell Mater 11: 16-26, discussion 26.
76. Arenson DM, Friedman SL, Bissell DM. 1988. Formation of extracellular matrix in normal rat liver: Lipocytes as a major source of proteoglycan. Gastroenterology 95: 441-447.
77. Friedman SL, Roll FJ, Boyles J, Bissell DM. 1985. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 82: 8681-8685.
78. Emerman JT, Burwen SJ, Pitelka DR. 1979. Substrate properties influencing ultrastructural differentiation of mammary epithelial cells in culture. Tissue Cell 11: 109-119.
79. Emerman JT, Pitelka DR. 1977. Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro 13: 316-328.
80. Lee EY, Lee WH, Kaetzel CS, Parry G, Bissell MJ. 1985. Interaction of mouse mammary epithelial cells with collagen substrata: Regulation of casein gene expression and secretion. Proc Natl Acad Sci USA 82: 1419-1423.
81. Lee EY, Parry G, Bissell MJ. 1984. Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata. J Cell Biol 98: 146-155.
82. Streuli CH, Bissell MJ. 1990. Expression of extracellular matrix components is regulated by substratum. J Cell Biol 110: 1405-1415.
83. Schmeichel KL, Bissell MJ. 2003. Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 116: 2377-2388.
84. Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. 2002. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 115: 39-50.
85. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. 1992. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89: 9064-9068.
86. Kenny PA, Bissell MJ. 2003. Tumor reversion: Correction of malignant behavior by microenvironmental cues. Int J Cancer 107: 688-695.
87. Liu H, Radisky DC, Wang F, Bissell MJ. 2004. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 164: 603-612.
88. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ. 1998. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology. Proc Natl Acad Sci USA 95: 14821-14826.
89. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. 1997. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245.
90. Dhiman HK, Ray AR, Panda AK. 2005. Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials 26: 979-986.
91. Bartholoma P, Impidjati, Reininger-Mack A, Zhang Z, Thielecke H, Robitzki A. 2005. A more aggressive breast cancer spheroid model coupled to an electronic capillary sensor system for a high-content screening of cytotoxic agents in cancer therapy: 3-dimensional in vitro tumor spheroids as a screening model. J Biomol Screen 10: 705-714.
92. Heneweer M, Muusse M, Dingemans M, de Jong PC, van den Berg M, Sanderson JT. 2005. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model. Toxicol Sci 83: 257-263.
93. Krause S, Maffini MV, Soto AM, Sonnenschein C. 2008. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng Part C Methods 14: 261-271.
94. Lippman ME, Osborne CK, Knazek R, Young N. 1977. In vitro model systems for the study of hormone-dependent human breast cancer. N Engl J Med 296: 154-159.
95. Mougel L, Tarpin M, Albert P, Le Naour R, Devy J, Kaplan H, Venteo L, Carlier A, Madoulet C. 2004. Three-dimensional culture and multidrug resistance: Effects on immune reactivity of MCF-7 cells by monocytes. Anticancer Res 24: 935-941.
96. Sahoo SK, Panda AK, Labhasetwar V. 2005. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules 6: 1132-1139.
97. Zimmermann WH, Eschenhagen T. 2003. Cardiac tissue engineering for replacement therapy. Heart Fail Rev 8: 259-269.
98. Papadaki M, Bursac N, Langer R, Merok J, Vunjak-Novakovic G, Freed LE. 2001. Tissue engineering of functional cardiac muscle: Molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol 280: H168-H178.
99. Liu XM, Liu H, Xiong FY, Chen ZL. 2003. Collagen membrane as scaffold for the three-dimensional cultivation of cardiac cells in vitro. Sheng Wu Gong Cheng Xue Bao 19: 484-488.
100. Auluck A, Mudera V, Hunt NP, Lewis MP. 2005. A three-dimensional in vitro model system to study the adaptation of craniofacial skeletal muscle following mechanostimulation. Eur J Oral Sci 113: 218-224.
101. Beier JP, Kneser U, Stern-Strater J, Stark GB, Bach AD. 2004. Y chromosome detection of three-dimensional tissue-engineered skeletal muscle constructs in a syngeneic rat animal model. Cell Transplant 13: 45-53.
102. Bouten CV, Breuls RG, Peeters EA, Oomens CW, Baaijens FP. 2003. In vitro models to study compressive strain-induced muscle cell damage. Biorheology 40: 383-388.
103. Breuls RG, Bouten CV, Oomens CW, Bader DL, Baaijens FP. 2003. Compression induced cell damage in engineered muscle tissue: An in vitro model to study pressure ulcer aetiology. Ann Biomed Eng 31: 1357-1364.
104. Cheema U, Yang SY, Mudera V, Goldspink GG, Brown RA. 2003. 3-D in vitro model of early skeletal muscle development. Cell Motil Cytoskeleton 54: 226-236.
105. Stankus JJ, Guan J, Fujimoto K, Wagner WR. 2006. Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials 27: 735-744.
106. Stegemann JP, Nerem RM. 2003. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture. Exp Cell Res 283: 146-155.
107. Hutmacher DW. 2001. Scaffold design and fabrication technologies for engineering tissues-State of the art and future perspectives. J Biomater Sci Polym Ed 12: 107-124.
108. Anderson EJ, Knothe Tate ML. 2007. Design of tissue engineering scaffolds as delivery devices for mechanical and mechanically modulated signals. Tissue Eng 13: 2525-2538.
109. Guan J, Stankus JJ, Wagner WR. 2006. Development of composite porous scaffolds based on collagen and biodegradable poly(ester urethane)urea. Cell Transplant 15: S17-S27.
110. Dennis RG, Kosnik PE II. 2000. Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim 36: 327-335.
111. Kosnik PE, Faulkner JA, Dennis RG. 2001. Functional development of engineered skeletal muscle from adult and neonatal rats. Tissue Eng 7: 573-584.
112. Botchwey EA, Pollack SR, El-Amin S, Levine EM, Tuan RS, Laurencin CT. 2003. Human osteoblast-like cells in three-dimensional culture with fluid flow. Biorheology 40: 299-306.
113. Mitsiades C, Sourla A, Doillon C, Lembessis P, Koutsilieris M. 2000. Three-dimensional type I collagen co-culture systems for the study of cell-cell interactions and treatment response in bone metastases. J Musculoskelet Neuronal Interact 1: 153-155.
114. Wenger A, Stahl A, Weber H, Finkenzeller G, Augustin HG, Stark GB, Kneser U. 2004. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng 10: 1536-1547.
115. Bancroft GN, Sikavitsas VI, Mikos AG. 2003. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng 9: 549-554.
116. Sikavitsas VI, Bancroft GN, Mikos AG. 2002. Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 62: 136-148.
117. Sikavitsas VI, van den Dolder J, Bancroft GN, Jansen JA, Mikos AG. 2003. Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model. J Biomed Mater Res A 67: 944-951.
118. Knothe Tate ML, Ritzman TF, Schneider E, Knothe UR. 2007. Testing of a new one-stage bone-transport surgical procedure exploiting the periosteum for the repair of long-bone defects. J Bone Joint Surg Am 89: 307-316.
119. Holy CE, Dang SM, Davies JE, Shoichet MS. 1999. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam. Biomaterials 20: 1177-1185.
120. Alaminos M, Sanchez-Quevdo MD, Munoz-Avila JI, Serrano D, Medialdea S, Carreras I, Campos A. 2006. Construction of a complete rabbit cornea substitute using a fibrin-agarose scaffold. Invest Ophthalmol Vis Sci 47: 3311-3317.
121. Duan XD, McLaughlin C, Griffith M, Sheardown H. 2007. Biofunctionalization of collagen for improved biological response: Scaffolds for corneal tissue engineering. Biomaterials 28: 78-88.
122. Germain L, Carrier P, Auger FA, Salesse C, Guerin SL. 2000. Can we produce a human corneal equivalent by tissue engineering? Prog Retin Eye Res 19: 497-527.
123. Griffith M, Osborne R, Munger R, Xiong XJ, Doillon CJ, Laycock NLC, Hakim M, Song Y, Watsky MA. 1999. Functional human corneal equivalents constructed from cell lines. Science 286: 2169-2172.
124. Reichl S, Bednarz J, Muller-Goymann CC. 2004. Human corneal equivalent as cell culture model for in vitro drug permeation studies. Br J Ophthalmol 88: 560-565.
125. Reichl S, Dohring S, Bednarz J, Muller-Goymann CC. 2005. Human cornea construct HCC-An alternative for in vitro permeation studies? A comparison with human donor corneas. Eur J Pharm Biopharm 60: 305-308.
126. Reichl S, Muller-Goymann CC. 2001. Development of an organotypical cornea construct as an in vitro model for permeation studies. Ophthalmologe 98: 853-858.
127. Tegtmeyer S, Papantoniou I, Muller-Goymann CC. 2001. Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride. Eur J Pharm Biopharm 51: 119-125.
128. Tegtmeyer S, Reichl S, Muller-Goymann CC. 2004. Cultivation and characterization of a bovine in vitro model of the cornea. Pharmazie 59: 464-471.
129. Watsky MA, Doillon CJ, Hakim M, Wang J, Munger R, Laycock N, Griffith M. 2002. A collagen-based scaffold for a tissue engineered human cornea: Physical and physiological properties. Invest Ophthalmol Vis Sci 43: U843-U843.
130. Zhao B, Cooper LJ, Brahma A, MacNeil S, Rimmer S, Fullwood NJ. 2006. Development of a three-dimensional organ culture model for corneal wound healing and corneal transplantation. Invest Ophthalmol Vis Sci 47: 2840-2846.
131. Zieske JD, Chung EH, Guo XQ, Hutcheon AEK. 2004. Human corneal organotypic cultures. J Toxicol Cutan Ocular Toxicol 23: 19-28.
132. Zorn-Kruppa M, Tykhonova S, Belge G, Bednarz J, Diehl HA, Engelke M. 2005. A human corneal equivalent constructed from SV40-immortalised corneal cell lines. Altern Lab Anim 33: 37-45.
133. Hsiao AY, Torisawa YS, Tung YC, Sud S, Taichman RS, Pienta KJ, Takayama S. 2009. Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. Biomaterials 30: 3020-3027.
134. Wong AP, Perez-Castillejos R, Christopher Love J, Whitesides GM. 2008. Partitioning microfluidic channels with hydrogel to construct tunable 3-D cellular microenvironments. Biomaterials 29: 1853-1861.
135. Lee PJ, Gaige TA, Ghorashian N, Hung PJ. 2007. Microfluidic tissue model for live cell screening. Biotechnol Prog 23: 946-951.
136. Tourovskaia A, Figueroa-Masot X, Folch A. 2005. Differentiation-on-a-chip: A microfluidic platform for long-term cell culture studies. Lab Chip 5: 14-19.
137. Toh YC, Lim TC, Tai D, Xiao G, van Noort D, Yu H. 2009. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 9: 2026-2035.
138. Ong SM, Zhang C, Toh YC, Kim SH, Foo HL, Tan CH, van Noort D, Park S, Yu H. 2008. A gel-free 3D microfluidic cell culture system. Biomaterials 29: 3237-3244.
139. Toh YC, Ng S, Khong YM, Samper V, Yu H. 2005. A configurable three-dimensional microenvironment in a microfluidic channel for primary hepatocyte culture. Assay Drug Dev Technol 3: 169-176.
140. Choi Y, McClain MA, LaPlaca MC, Frazier AB, Allen MG. 2007. Three dimensional MEMS microfluidic perfusion system for thick brain slice cultures. Biomed Microdevices 9: 7-13.
141. Toh YC, Zhang C, Zhang J, Khong YM, Chang S, Samper VD, van Noort D, Hutmacher DW, Yu H. 2007. A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip 7: 302-309.
142. Kim MS, Yeon JH, Park JK. 2007. A microfluidic platform for 3-dimensional cell culture and cell-based assays. Biomed Microdevices 9: 25-34.
143. Wu LY, Di Carlo D, Lee LP. 2008. Microfluidic self-assembly of tumor spheroids for anticancer drug discovery. Biomed Microdevices 10: 197-202.
144. Ng CP, Pun SH. 2008. A perfusable 3D cell-matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport. Biotechnol Bioeng 99: 1490-1501.
145. Tatosian DA, Shuler ML. 2009. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers. Biotechnol Bioeng 103: 187-198.
146. Bischoff KB, Dedrick RL, Zaharko DS, Longstreth JA., 1971. Methotrexate pharmacokinetics. J Pharm Sci 60: 1128-1133.
147. Henshaw JW, Yuan F. 2008. Field distribution and DNA transport in solid tumors during electric field-mediated gene delivery. J Pharm Sci 97: 691-711.
148. Jain RK. 1998. The next frontier of molecular medicine-Delivery of therapeutics. Nat Med 4: 655-657.
149. McGuire S, Zaharoff D, Yuan F. 2002. Interstitial transport of macromolecules: Implication for nucleic acid delivery in solid tumors. In: Mahato RI, Kim SW, editors. Pharmaceutical perspectives of nucleic acid-based therapeutics. edition. London: Taylor & Francis Books. pp. 434-454.
150. Wang Y, Yuan F. 2006. Delivery of viral vectors to tumor cells: Extracellular transport, systemic distribution, and strategies for improvement. Ann Biomed Eng 34: 114-127.
151. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. 1953. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638-648.
152. Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. 2002. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 7: 492-508.
153. Shannon AM, Bouchier-Hayes DJ, Condron CM, Toomey D. 2003. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev 29: 297-307.
154. Teicher BA. 1994. Hypoxia and drug resistance. Cancer Metastasis Rev 13: 139-168.
155. Tredan O, Galmarini CM, Patel K, Tannock IF. 2007. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99: 1441-1454.
156. Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, Jain RK. 2001. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 7: 864-868.
157. Jain RK, Munn LL, Fukumura D. 2002. Transparent window models and intravital microscopy: Imaging gene expression, physiological function, and drug delivery in tumors. In: Teicher BA, editor. Tumor models in cancer research. edition. Totowa, NJ: Humana Press.
158. Casciari JJ, Hollingshead MG, Alley MC, Mayo JG, Malspeis L, Miyauchi S, Grever MR, Weinstein JN. 1994. Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model. J Natl Cancer Inst 86: 1846-1852.
159. Sutherland RM, Durand RE. 1976. Radiation response of multicell spheroids-An in vitro tumour model. Curr Top Radiat Res Q 11: 87-139.
160. Brown JM, Giaccia AJ. 1998. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416.
161. Bush RS, Jenkin RD, Allt WE, Beale FA, Bean H, Dembo AJ, Pringle JF. 1978. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl 37: 302-306.
162. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, Broder GJ. 1988. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838.
163. Durand RE. 1990. Multicell spheroids as a model for cell kinetic studies. Cell Tissue Kinet 23: 141-159.
164. Durand RE, Olive PL. 1992. Evaluation of bioreductive drugs in multicell spheroids. Int J Radiat Oncol Biol Phys 22: 689-692.
165. Durand RE, Olive PL. 1992. Tumour cell kinetics and heterogeneity: Insights from multicell spheroids. BJR Suppl 24: 79-83.
166. Freyer JP, Sutherland RM. 1983. Determination of diffusion constants for metabolites in multicell tumor spheroids. Adv Exp Med Biol 159: 463-475.
167. Groebe K, Erz S, Mueller-Klieser W. 1994. Glucose diffusion coefficients determined from concentration profiles in EMT6 tumor spheroids incubated in radioactively labeled L-glucose. Adv Exp Med Biol 361: 619-625.
168. Nederman T, Acker H, Carlsson J. 1983. Penetration of substances into tumor tissue: A methodological study with microelectrodes and cellular spheroids. In Vitro 19: 479-488.
169. Nederman T, Carlsson J, Kuoppa K. 1988. Penetration of substances into tumour tissue. Model studies using saccharides, thymidine and thymidine-5'-triphosphate in cellular spheroids. Cancer Chemother Pharmacol 22: 21-25.
170. Nederman T, Carlsson J, Malmqvist M. 1981. Penetration of substances into tumor tissue-A methodological study on cellular spheroids. In Vitro 17: 290-298.
171. Olive PL, Durand RE. 1983. Penetration of AF-2 and 4NQO into multicell spheroids. Environ Mutagen 5: 553-563.
172. Herrmann R, Fayad W, Schwarz S, Berndtsson M, Linder S. 2008. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids. J Biomol Screen 13: 1-8.
173. Teicher BA, Herman TS, Holden SA, Wang YY, Pfeffer MR, Crawford JW, Frei E III. 1990. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 247: 1457-1461.
174. Kobayashi H, Man S, Graham CH, Kapitain SJ, Teicher BA, Kerbel RS. 1993. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci USA 90: 3294-3298.
175. Nicholson KM, Bibby MC, Phillips RM. 1997. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids. Eur J Cancer 33: 1291-1298.
176. Francia G, Green SK, Bocci G, Man S, Emmenegger U, Ebos JM, Weinerman A, Shaked Y, Kerbel RS. 2005. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: Implications for multicellular resistance to alkylating agents. Mol Cancer Ther 4: 1484-1494.
177. Chen YY, Wang ZX, Chang PA, Li JJ, Pan F, Yang L, Bian ZH, Zou L, He JM, Liang HJ. 2009. Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance. Cancer Sci 100: 1708-1713.
178. Teicher BA. 2009. Acute and chronic in vivo therapeutic resistance. Biochem Pharmacol 77: 1665-1673.
179. Casciari JJ, Sotirchos SV, Sutherland RM. 1992. Mathematical modelling of microenvironment and growth in EMT6/Ro multicellular tumour spheroids. Cell Prolif 25: 1-22.
180. Sutherland RM, Inch WR, McCredie JA, Kruuv J. 1970. A multi-component radiation survival curve using an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med 18: 491-495.
181. Jessup JM, Frantz M, Sonmez-Alpan E, Locker J, Skena K, Waller H, Battle P, Nachman A, Bhatti Weber ME, Thomas DA, Curbeam RL Jr, Baker TL, Goodwin TJ. 2000. Microgravity culture reduces apoptosis and increases the differentiation of a human colorectal carcinoma cell line. In Vitro Cell Dev Biol Anim 36: 367-373.
182. Ingram M, Techy GB, Saroufeem R, Yazan O, Narayan KS, Goodwin TJ, Spaulding GF. 1997. Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell Dev Biol Anim 33: 459-466.
183. Goodwin TJ, Prewett TL, Wolf DA, Spaulding GF. 1993. Reduced shear stress: A major component in the ability of mammalian tissues to form three-dimensional assemblies in simulated microgravity. J Cell Biochem 51: 301-311.
184. Schwarz RP, Goodwin TJ, Wolf DA. 1992. Cell culture for three-dimensional modeling in rotating-wall vessels: An application of simulated microgravity. J Tissue Cult Methods 14: 51-57.
185. Clejan S, O'Connor K, Rosensweig N. 2001. Tri-dimensional prostate cell cultures in simulated microgravity and induced changes in lipid second messengers and signal transduction. J Cell Mol Med 5: 60-73.
186. Clejan S, O'Connor KC, Cowger NL, Cheles MK, Haque S, Primavera AC. 1996. Effects of simulated microgravity on DU 145 human prostate carcinoma cells. Biotechnol Bioeng 50: 587-597.
187. Kelm JM, Timmins NE, Brown CJ, Fussenegger M, Nielsen LK. 2003. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83: 173-180.
188. Emfietzoglou D, Kostarelos K, Papakostas A, Yang WH, Ballangrud A, Song H, Sgouros G. 2005. Liposome-mediated radiotherapeutics within avascular tumor spheroids: Comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibody. J Nucl Med 46: 89-97.
189. Zhang X, Wang W, Yu W, Xie Y, Zhang Y, Ma X. 2005. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol Prog 21: 1289-1296.
190. Hlatky L, Alpen EL. 1985. Two-dimensional diffusion limited system for cell growth. Cell Tissue Kinet 18: 597-611.
191. Hlatky L, Ring C, Sachs RK. 1989. Comparison of 3H-misonidazole binding between CHO and 9L cells using the sandwich system. Int J Radiat Oncol Biol Phys 16: 943-947.
192. Hlatky L, Ring CS, Sachs RK. 1989. 3H-misonidazole labeling and viability of hypoxic cells in the sandwich system, an in vitro tumor analogue. Int J Radiat Oncol Biol Phys 16: 143-153.
193. Hassan SB, de la Torre M, Nygren P, Karlsson MO, Larsson R, Jonsson E. 2001. A hollow fiber model for in vitro studies of cytotoxic compounds: Activity of the cyanoguanidine CHS 828. Anticancer Drugs 12: 33-42.
194. Cowan DS, Hicks KO, Wilson WR. 1996. Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Br J Cancer Suppl 27: S28-S31.
195. Hicks KO, Ohms SJ, van Zijl PL, Denny WA, Hunter PJ, Wilson WR. 1997. An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. Br J Cancer 76: 894-903.
196. Hicks KO, Fleming Y, Siim BG, Koch CJ, Wilson WR. 1998. Extravascular diffusion of tirapazamine: Effect of metabolic consumption assessed using the multicellular layer model. Int J Radiat Oncol Biol Phys 42: 641-649.
197. Hicks KO, Pruijn FB, Baguley BC, Wilson WR. 2001. Extravascular transport of the DNA intercalator and topoisomerase poison N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA): Diffusion and metabolism in multicellular layers of tumor cells. J Pharmacol Exp Ther 297: 1088-1098.
198. Hicks KO, Pruijn FB, Sturman JR, Denny WA, Wilson WR. 2003. Multicellular resistance to tirapazamine is due to restricted extravascular transport: A pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures. Cancer Res 63: 5970-5977.
199. Minchinton AI, Wendt KR, Clow KA, Fryer KH. 1997. Multilayers of cells growing on a permeable support. An in vitro tumour model. Acta Oncol 36: 13-16.
200. Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ. 2002. Limited penetration of anticancer drugs through tumor tissue: A potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 8: 878-884.